Immune-mediated thrombotic thrombocytopenic purpura: don't miss the boat

Intensive Care Med. 2024 Feb;50(2):287-290. doi: 10.1007/s00134-023-07300-8. Epub 2024 Jan 9.

Authors

Adrien Picod¹, Lara Zafrani¹, Elie Azoulay²

Affiliations

¹ Médecine Intensive et Réanimation, APHP, Hôpital Saint-Louis, Paris University, 1 Avenue Claude Vellefaux, 75010, Paris, France.
² Médecine Intensive et Réanimation, APHP, Hôpital Saint-Louis, Paris University, 1 Avenue Claude Vellefaux, 75010, Paris, France. elie.azoulay@aphp.fr.

PMID: 38193904
DOI: 10.1007/s00134-023-07300-8

No abstract available

Keywords: Acute heart failure; Acute kidney injury; Caplacizumab; Thrombocytopenia; Thrombotic microanigiopathy.

MeSH terms

ADAMTS13 Protein
Humans
Plasma Exchange
Purpura, Thrombotic Thrombocytopenic* / therapy

Substances

ADAMTS13 Protein